Recent FDA Approvals in the Treatment of Graft-Versus-Host Disease

Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic cell transplantation (HCT) and is associated with significant morbidity and mortality. For many years, there have been few effective treatment options for patients with GVHD. First-line systemic treatment remains c...

Descripción completa

Detalles Bibliográficos
Autores principales: Martini, Dylan J, Chen, Yi-Bin, DeFilipp, Zachariah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Hematologic Malignancies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355804/
https://www.ncbi.nlm.nih.gov/pubmed/35443042
http://dx.doi.org/10.1093/oncolo/oyac076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355804/
https://www.ncbi.nlm.nih.gov/pubmed/35443042
http://dx.doi.org/10.1093/oncolo/oyac076

Ejemplares similares